Pharmacokinetics and Pharmacodynamics of TBR-652, a Novel CCR5 Antagonist, in HIV-1-Infected, Antiretroviral Treatment-experienced and CCR5 Antagonist-naive Patients

Author(s): Jean-Francois Marier, MyMy Trinh, Leng Hong Pheng, Sandra Palleja, and David Martin
Year: April 12, 2011
Learn More LinkedIn Twitter Facebook Email